Loading company…
MEDx provides biomarker services and molecular testing for pharmaceutical companies and clinical trials.
Founded in 2013 and based in Suzhou, China, MEDx provides translational medicine services, including biomarker discovery and validation, assay development, molecular testing and patient screening for clinical trials. It also develops and commercializes companion diagnostic kits. As of 2023, the company had more than 200 pharmaceutical customers and more than 200 biomarker discovery and detection methods.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in